Deep Learning and Machine Learning Usage in Cirrhosis Prediction: A Comparative Study

Abstract

The cirrhosis disease represents the final stage of hepatitis, characterized by the death of liver cells and irreversible liver damage. Although there are some methods used in the prediction of cirrhosis, especially those utilizing various artificial intelligence techniques, it is still difficult to accurately predict cirrhosis. The aim of this research is to detect cirrhosis by focusing on deep learning methods. In addition to analyzing the performance of deep learning methods for cirrhosis prediction, the study also compares the performance of traditional machine learning algorithms with deep learning techniques. Decision Tree (DT), k-Nearest Neighbors (kNN), Random Forest (RF) and Logistic Regression (LR) algorithms are used in order to achieve these goals. Considering the relatively lower performance of some of these algorithms, Deep Neural Networks performed the classification accurately. In the dataset used in the study, there were 362 patients with cirrhosis and 1023 without cirrhosis. Model performance showed that deep neural networks achieved high classification performance with metrics such as 95.96% accuracy. According to the results, deep learning methods showed strong performance, providing high accuracy and sensitivity for cirrhosis prediction alongside traditional machine learning methods.

Keywords

• Cirrhosis
• Deep neural networks
• Hepatitis C virus
• Machine learning
• Classification
• Performance evaluation

References

1. Arslan RU, Pamuk Z, Kaya C. 2024. Usage of Weka software based on machine learning algorithms for prediction of liver fibrosis/cirrhosis. BSJ Eng Sci, 7(3): 445-456.
2. Bayrak EA, Kırcı P, Ensari T. 2019. Performance analysis of machine learning algorithms and feature selection methods on hepatitis disease. Int J Multidiscip Stud Innov Technol, 3(2): 135–138.
3. Bergstra J, Bengi Y. 2012. Random search for hyper-parameter optimization. J Mach Learn Res, 13(1): 281-305.
4. Bertsimas D, King A. 2017. Logistic Regression: From Art to Science. Stat Sci, 32(3): 367–384.
5. Chen SL, Morgan TR. 2006. The natural history of hepatitis C virus (HCV) infection. Int J Med Sci, 3(2): 47–52.
6. Clevert DA, Unterthiner T, Hochreiter S. 2016. Fast and accurate deep network learning by exponential linear units (ELUs). URL: https://doi.org/10.48550/arXiv.1511.07289 (accessed date: October 28, 2025).
7. El Houby EMF. 2018. A survey on applying machine learning techniques for management of diseases. J Appl Biomed, 16(3): 165–174.
8. Filiz E, Akogul S, Karaboğa HA. 2021. Büyük dünya endeksleri kullanılarak BIST-100 endeksi değişim yönünün makine öğrenmesi algoritmaları ile sınıflandırılması. Bitlis Eren Univ Fen Bilim Derg, 10(2): 432-441.

9. Filiz E, Karaboğa HA, Akoğul S. 2017. BIST-50 endeksi değişim değerlerinin sınıflandırılmasında makine öğrenmesi yöntemleri ve yapay sinir ağları kullanımı. Çukurova Üniv Sosyal Bil Enst Derg, 26(1): 231–241.
10. Goossens N, Clément S, Negro F. (eds.) 2016. Handbook of hepatitis C. Springer International Publishing, Cham., NY, USA, 1st ed.
11. Hashem S, Esmat G, Elakel W, Habashy S, Raouf SA, Elhefnawi M, ElHefnawi M. 2018. Comparison of machine learning approaches for prediction of advanced liver fibrosis in chronic hepatitis C patients. IEEE/ACM Trans Comput Biol Bioinform, 15(3): 861–868.
12. Haydon GH, Jalan R, Ala-Korpela M, Hiltunen Y, Hanley J, Jarvis LM, Hayes PC. 1998. Prediction of cirrhosis in patients with chronic hepatitis C infection by artificial neural network analysis of virus and clinical factors. J Viral Hepat, 5(4): 255–264.
13. He H, Bai Y, Garcia EA, Li S. 2008. ADASYN: Adaptive synthetic sampling approach for imbalanced learning. In: 2008 IEEE international joint conference on neural networks (IEEE world congress on computational intelligence), June 1-8, Hong Kong, pp: 1322-1328.
14. Hosmer Jr DW, Lemeshow S, Sturdivant RX. 2013. Applied logistic regression. John Wiley Sons, Hoboken, NJ. USA, 1st ed.
15. Imbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, Poynard T. 2001. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: A prospective study. Lancet, 357(9262): 1069–1075.
16. Karaboga HA, Gunel A, Korkut SV, Demir I, Celik R. 2021. Bayesian Network as a decision tool for predicting ALS disease. Brain Sci, 11(2): 150.
17. Koca MB, Nourani E, Abbasoğlu F, Karadeniz İ, Sevilgen FE. 2022. Graph convolutional network-based virus-human protein-protein interaction prediction for novel viruses. Comput Biol Chem, 101: 107755.
18. Konerman MA, Zhang Y, Zhu J, Higgins PDR, Lok ASF, Waljee AK. 2015. Improvement of predictive models of risk of disease progression in chronic hepatitis C by incorporating longitudinal data. Hepatology, 61(6): 1832–1841.
19. Leng H, Zhang Z, Chen C, Chen C. 2024. A class-imbalanced hybrid learning strategy based on Raman spectroscopy of serum samples for the diagnosis of hepatitis B, hepatitis A, and thyroid dysfunction. Spectrochim Acta A Mol Biomol Spectrosc, 320: 124581.
20. Limketkai BN, Mehta SH, Sutcliffe CG, Higgins YM, Torbenson MS, Brinkley SC, Sulkowski MS. 2012. Relationship of liver disease stage and antiviral therapy with liver-related events and death in adults coinfected with HIV/HCV. JAMA, 308(4): 370–378.
21. Meewan I, Panmanee J, Petchyam N, Lertvilai P. 2024. HBCVTr: an end-to-end transformer with a deep neural network hybrid model for anti-HBV and HCV activity predictor from SMILES. Sci Rep, 14(1): 9262.
22. Nandipati SC, XinYing C, Wah KK. 2020. Hepatitis C virus (HCV) prediction by machine learning techniques. Appl of Model and Simul, 4(1): 89-100.
23. Nasr M, El-Bahnasy K, Hamdy M, Kamal SM. 2017. A novel model based on non-invasive methods for prediction of liver fibrosis. In: Proc 2017 13th Int Comput Eng Conf (ICENCO), December 27-28, Cairo, EGYPT, pp: 276–281.
24. Nickbakhsh S, McLauchlan J, Leitch ECM. 2018. Evaluating “treatment as prevention” on the road to hepatitis C virus elimination. Ann Blood, 3(0): 402-411.
25. Pournik O, Dorri S, Zabolinezhad H, Alavian SM, Eslami S. 2014. A diagnostic model for cirrhosis in patients with non-alcoholic fatty liver disease: An artificial neural network approach. Med J Islam Repub Iran, 28(1): 116.
26. Reiser M, Wiebner B, Hirsch J. 2019. Neural-network analysis of socio-medical data to identify predictors of undiagnosed hepatitis C virus infections in Germany (DETECT). J Transl Med, 17(1): 94.
27. Rinella ME. 2015. Nonalcoholic fatty liver disease: A systematic review. JAMA, 313(22): 2263–2273.
28. Rouhani M, Haghighi MM. 2009. The diagnosis of hepatitis diseases by support vector machines and artificial neural networks. In: Proc 2009 Int Assoc Comput Sci Inf Technol Spring Conf (IACSIT-SC), April 17-20, Singapore, pp: 456–458.
29. Sathya C, Uma Maheswari N. 2023. Comparative analysis of machine learning and deep learning techniques for liver disease prediction. In: Sivakumar Reddy V, Wang J, Reddy KTV, editors. International Conference on Soft Computing and Signal Processing. Springer Nature Singapore, Singapore, pp: 445-455.
30. Schuppan D, Afdhal NH. 2008. Liver cirrhosis. The Lancet, 371(9615): 838–851.
31. Song Y, Lu Y. 2015. Decision tree methods: Applications for classification and prediction. Shanghai Arch Psychiatry, 27(2): 130–135.
32. Sweidan S, El-Bakry H, Mastorakis N. 2016. Viral hepatitis diagnosis: A survey of artificial ıntelligent techniques. Int J Biol Biomed, 1(1): 106-116.
33. Thirumarai Selvi C, Muthukrishnan M, Gopalakrishnan A. 2023. Automatic hybrid deep learning network for ımage lesion prognosis and diagnosis. In: Spurgeon JJ, Appadurai M, Joshua ES, editors. Translating Healthcare Through Intelligent Computational Methods. Springer International Publishing, Cham, pp: 125-133.
34. Tsochatzis EA, Bosch J, Burroughs AK. 2014. Liver cirrhosis. Lancet, 383(9930): 1749–1761.
35. Waked IA, Saleh SM, Moustafa MS, Raouf AA, Thomas DL, Strickland GT. 1995. High prevalence of hepatitis C in Egyptian patients with chronic liver disease. Gut, 37(1): 105–107.
36. Wei R, Wang J, Wang X, Xie G, Wang Y, Zhang H, Jia W. 2018. Clinical prediction of HBV and HCV related hepatic fibrosis using machine learning. EBioMedicine, 35: 124–132.
37. Zhai Y, Hai D, Zeng L, Lin C, Tan X, Mo Z, Pan J. 2024. Artificial intelligence-based evaluation of prognosis in cirrhosis. J Transl Med, 22: 933.